Drag

Ind-Swift Laboratories Limited

Healthcare INDSWFTLAB

113.41INR
6.10 ( 5.68%)

Last update at 2026-01-30 15:58:01

Day Range

107.09117.80
LowHigh

52 Week Range

68.72 124.00
LowHigh

Fundamentals

  • Previous Close 107.31
  • Market Cap 7464.26M
  • Volume753,731
  • P/E Ratio 2.82
  • EBITDA -23.91M
  • Revenue TTM 5717.71M
  • Revenue Per Share TTM 77.76
  • Gross Profit TTM 3022.96M
  • Diluted EPS TTM 32.39

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 2577.99M 5817.57M 865.21M 125.32M 180.09M
Net income 2504.77M 4209.62M 475.97M -21.49M -31.47M
Total Revenue 5617.13M 12809.00M 12073.10M 10387.34M 8913.45M
Gross Profit 2737.60M 4133.22M 4404.47M 4096.13M 3751.05M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 14383.39M 14604.34M 18240.64M 18008.30M 18184.49M
Intangible assets 106.81M 105.22M 0.00M 10.00M 92.01M
Other current assets 1050.07M 1875.26M 1740.32M 0.00M 680.87M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -664.69M 4132.80M -44.06M 141.69M 10.29M
Operating Cash -254.74M -1631.15M 1946.20M 1502.74M 1349.47M
Free Cash Flow -898.80M -2076.32M 1818.49M 1318.59M 1305.51M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
INDSWFTLAB
Ind-Swift Laboratories Limited 		6.10 5.68% 113.41 7464.26 2.82
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-6.60 -0.39% 1696.00 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-116.50 -1.90% 6025.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-40.70 -1.02% 3935.70 1362716.66 63.48
CIPLA
Cipla Limited 		-7.20 -0.54% 1326.10 1183505.97 21.74

Profile

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.

Ind-Swift Laboratories Limited

Shivalik Enclave, Manimajra, India, 160101

Key Executives

Name Title Year Born
Mr. Navrattan Munjal Chairman & MD 1952
Mr. Himanshu Jain BCom Joint MD & Whole Time Director 1982
Mr. Rishav Mehta Exec. Director 1991
Mr. Sahil Munjal Pres of Operations & Special Assignments & Exec. Director 1980
Mr. Sunil Deshmukh Chief Exec. Officer NA
Mr. Gagan Aggarwal Chief Financial Officer NA
Mr. Lovekesh Mahajan Chief Accounts Officer NA
Mr. Pardeep Verma Assistant VP of Corp. Affairs, Compliance Officer & Company Sec. NA
Mr. Atul Chaubey Group Head of HR NA
Mr. Vikas Narendra Pres of US Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.